John Pezzuto to Drug Design
This is a "connection" page, showing publications John Pezzuto has written about Drug Design.
Connection Strength
0.270
-
Pezzuto JM, Kondratyuk TP, Ogas T. Resveratrol derivatives: a patent review (2009 - 2012). Expert Opin Ther Pat. 2013 Dec; 23(12):1529-46.
Score: 0.100
-
Conda-Sheridan M, Park EJ, Beck DE, Reddy PV, Nguyen TX, Hu B, Chen L, White JJ, van Breemen RB, Pezzuto JM, Cushman M. Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potential. J Med Chem. 2013 Mar 28; 56(6):2581-605.
Score: 0.096
-
Kang YH, Pezzuto JM. Induction of quinone reductase as a primary screen for natural product anticarcinogens. Methods Enzymol. 2004; 382:380-414.
Score: 0.051
-
Archer CR, Groll M, Stein ML, Schellenberg B, Clerc J, Kaiser M, Kondratyuk TP, Pezzuto JM, Dudler R, Bachmann AS. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells. Biochemistry. 2012 Aug 28; 51(34):6880-8.
Score: 0.023